CervoMed Inc. (CRVO)
CervoMed Statistics
Share Statistics
CervoMed has 8.7M shares outstanding. The number of shares has increased by 5.44% in one year.
| Shares Outstanding | 8.7M |
| Shares Change (YoY) | 5.44% |
| Shares Change (QoQ) | 5.44% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 5.64M |
| Failed to Deliver (FTD) Shares | 774.99K |
| FTD / Avg. Volume | 16.3% |
Short Selling Information
The latest short interest is 1.24M, so 15.07% of the outstanding shares have been sold short.
| Short Interest | 1.24M |
| Short % of Shares Out | 15.07% |
| Short % of Float | 23.25% |
| Short Ratio (days to cover) | 3.11 |
Valuation Ratios
The PE ratio is -1.16 and the forward PE ratio is -1.22. CervoMed's PEG ratio is -0.01.
| PE Ratio | -1.16 |
| Forward PE | -1.22 |
| PS Ratio | 0 |
| Forward PS | 5.5 |
| PB Ratio | 0.48 |
| P/FCF Ratio | -1.14 |
| PEG Ratio | -0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CervoMed.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.11, with a Debt / Equity ratio of 0.
| Current Ratio | 11.11 |
| Quick Ratio | 11.11 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.09M |
| Employee Count | 15 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -47.97% in the last 52 weeks. The beta is 0.19, so CervoMed's price volatility has been higher than the market average.
| Beta | 0.19 |
| 52-Week Price Change | -47.97% |
| 50-Day Moving Average | 4.7 |
| 200-Day Moving Average | 10.25 |
| Relative Strength Index (RSI) | 61.01 |
| Average Volume (20 Days) | 4.76M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -18.23M |
| Net Income | -16.29M |
| EBITDA | -18.23M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2.02 |
Balance Sheet
The company has 9M in cash and 0 in debt, giving a net cash position of 9M.
| Cash & Cash Equivalents | 9M |
| Total Debt | 0 |
| Net Cash | 9M |
| Retained Earnings | -70.73M |
| Total Assets | 43.08M |
| Working Capital | 39.2M |
Cash Flow
In the last 12 months, operating cash flow was -16.53M and capital expenditures 0, giving a free cash flow of -16.53M.
| Operating Cash Flow | -16.53M |
| Capital Expenditures | 0 |
| Free Cash Flow | -16.53M |
| FCF Per Share | -2.05 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CRVO is $17.5, which is 55.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.5 |
| Price Target Difference | 55.4% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on Aug 17, 2023. It was a backward split with a ratio of 2:3.
| Last Split Date | Aug 17, 2023 |
| Split Type | backward |
| Split Ratio | 2:3 |
Scores
| Altman Z-Score | 10.96 |
| Piotroski F-Score | 2 |